Clalit

Google.org awards Clalit $2 million to develop AI system for patient access

Google.org awards Clalit $2m. to build multilingual AI that helps patients book care, complete intake, and access healthcare more easily

Clalit health center in Ramla, central Israel. June 10, 2026; Illustrative.
Robotic lung transplant surgery at Clalit-Beilinson Hospital

Israeli surgeons complete robotic lung transplant without fully opening chest, spreading ribs

An illustrative image of AI chatbots and medical assistants for digital health consultations and online medical support.

Can AI tell when patients don't need medical tests? Israeli study puts chatbots to the test

The medical team during implantation of the EASEE system at Clalit-Beilinson Hospital. From right: Dr. Idit Tamir, Professor Felix Benninger, Dr. Ilan Goldberg and Dr. Maison Hajj.

Israeli patient receives new non-invasive treatment for epilepsy in first outside Europe


Beilinson Friends Forum hosts event for cancer innovation in Israel

A generous endowment from Drs. Susan and Henry Samueli is expected to give cancer treatment and research in Israel an extra leg up.

 Prof. Gal Markel Director of the Davidoff Center and the Samueli Institute in Bilinson The couple Dr. Henry and Dr. Susan Samueli Dr. Eitan Wertheim Director of the Bilinson and Sharon Hospitals and Finny (Pinchas) Cohen Yore Association Friends of the Medical Center

Gaza border families invited to the Negev to relieve stress

Meir Tzur, head of the Central Arava Regional Council, said that he hopes that they feel safe and calm away from the hustle and bustle.

Zukim village, a new village based on ecological tourism.

Drinking green tea can have dangerous consequences - Israeli study

Researchers from Israel's Kaplan Medical Center discovered that drinking too much green tea can cause significant damage to the liver.

 Green tea: Can a soothing natural drink have dangerous consequences? (Illustrative)

Israeli Meir Medical Center welcomes four sets of twins in 24 hours

Eight bundles of joy were successfully delivered at a Clalit-affiliated hospital in Kfar Saba.

 Four sets of twins were successfully delivered within the same 24 hour period in Kfar Saba.

Omicron booster vaccine reduces COVID hospitalization, death among elderly

Clalit study is the first in the world to prove new reformulated Omicron vaccine protects the elderly and immunocompromised from hospitalization and death.

 A NURSE prepares a dose of the COVID-19 vaccine as the new Omicron variant spreads, in Dutywa, in Eastern Cape province, South Africa this week.

First comprehensive study on monkeypox vaccine efficacy conducted in Israel

Researchers in Israel tested the effectiveness of giving a single dose of the vaccine to prevent cases of symptomatic monkeypox infection.

 An electron microscopic (EM) image shows mature, oval-shaped monkeypox virus particles as well as crescents and spherical particles of immature virions, obtained from a clinical human skin sample associated with the 2003 prairie dog outbreak in this undated image obtained by Reuters on May 18, 2022

Clalit gives mascot a baseball cap as Deri takes over Health Ministry

The mascot's creator, Daniela London-Dekel, responded: "If it were up to me, Hamoodi would receive the new health minister with two hands outstretched forward with prison uniforms."

 Hamoodi's portrayal for haredi audiences.

Healthcare 2040: Could doctors predict your medical future?

Effectively collaborating with computers could help reduce errors and allow healthcare to shift from supplying patient-level, reactive therapeutics to predictive, proactive and preventative care.

 Gil Shwed (right) discusses rise in cyber attacks in the healthcare arena.

Paxlovid reduces risk of COVID-19 death by 81%, Clalit study shows

So far, over 30,000 COVID-19 patients in Israel have been treated with the anti-viral Paxlovid drug.

 Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in boxes, at Misericordia hospital in Grosseto, Italy, February 8, 2022.

Fourth coronavirus vaccine dose lowers mortality risk fourfold - study

Patients who received the fourth dose were 76% less likely to die compared to those who received just the third dose.

  Israelis receiving their fourth coronavirus vaccine, January 3, 2022.